Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: took the shot on 30april2022 and tested positive for covid/rapid test and the results were positive; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (took the shot on 30april2022 and tested positive for covid/rapid test and the results were positive) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056A21A, 939903, 038B21A and 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Tooth infection.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (took the shot on 30april2022 and tested positive for covid/rapid test and the results were positive). At the time of the report, COVID-19 (took the shot on 30april2022 and tested positive for covid/rapid test and the results were positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-May-2022, SARS-CoV-2 test: positive (Positive) Positive.         At the time of reporting patient taking some antibiotics for an infection in his teeth. It was reported that patient first time tested positive for Covid-19.  No treatment medication information was provided.  Company comment: This spontaneous case concerns a 62-year-old male patient, with no reported relevant medical history, who experienced, unexpected, non-serious, COVID-19, the same day after receiving the fourth dose of mRNA-1273 vaccine as a second booster dose.  The patient received mRNA-1273 vaccine as primary COVID-19 vaccine and has received a third dose of mRNA-1273 vaccine as a first booster dose approximately 6 months before receiving the second booster dose.  On the day of vaccination, the patient underwent SARS-CoV-2 rapid test which showed positive result.  The patient also underwent PCR test, and the result is still pending.  The outcome of the event was unknown.  Clinical course and treatment details are not available in this report.  The ongoing pandemic could be considered as possible confounder for the event.  The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 62-year-old male patient, with no reported relevant medical history, who experienced, unexpected, non-serious, AESI of COVID-19, the same day after receiving the fourth dose of mRNA-1273 vaccine as a second booster dose.  The patient received mRNA-1273 vaccine as primary COVID-19 vaccine and has received a third dose of mRNA-1273 vaccine as a first booster dose approximately 6 months before receiving the second booster dose.  On the day of vaccination, the patient underwent SARS-CoV-2 rapid test which showed positive result.  The patient also underwent PCR test, and the result is still pending.  The outcome of the event was unknown.  Clinical course and treatment details are not available in this report.  The ongoing pandemic could be considered as possible confounder for the event.  The benefit-risk relationship of mRNA-1273 is not affected by this report.